# Progress Note 02 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Elizabeth I (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-RE003-SYN
- Date: 2026-01-26
- Fictional facility: St. Posthumous Health Center
- Fictional author: Philippa Ashcombe-Nwosu, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Two-week review of results for low mood and weight loss; geriatric psychiatry consultation today. **S**

## History of present illness

Ms. Tudor returns two weeks after her first visit. She stopped the over-the-counter diphenhydramine that night; for three nights she slept worse, and she now sleeps about four hours, waking at 2 or 3 in the morning and lying awake with thoughts of the friends she has lost. She has kept the sleep diary and the fixed rising time and has stopped napping after dinner. Her appetite is still poor; she takes the nutrition supplement once a day and has lost a further 0.3 kg. She still postpones audiences and has not played music or ridden. She has not had the wish not to wake since the first visit and has no thoughts of harming herself; she keeps her safety plan in her desk. She saw Dr. Rasmussen-Hale of geriatric psychiatry this afternoon. She came at the end of the day, as arranged, and asks again that nothing about her care leave the clinic. **S**

| Element | Detail |
|---|---|
| Sleep | About four hours, with early waking; diphenhydramine stopped; sleep diary kept |
| Appetite and weight | Poor; 52.1 kg, down 0.3 kg |
| Function | Still postponing audiences; no music or riding |
| Safety | No passive death wish since intake; no thoughts of self-harm |
| PHQ-9 | 16, down from 17; item 9 scored 0 |
| Insomnia Severity Index | 19 (moderate) |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Poor appetite; tired; no fever or night sweats |
| Gastrointestinal | Negative | No abdominal pain, dysphagia, or change in bowel habit |
| Neurological | Negative | No memory complaints, unsteadiness, or tremor |
| Psychiatric | Positive | Low mood, loss of interest, early waking, and guilt about a lost friend; no suicidal thoughts; no elevated mood or racing thoughts |

4 systems reviewed. **S**

## Current medications

- Sertraline 25 mg oral tablet, one tablet by mouth each morning **S**

## Allergies

- No known allergy **S**

## Objective

BP 126/74 mmHg; pulse 76 bpm; respirations 14/min; temperature 36.5 °C; oxygen saturation 98% on room air; weight 52.1 kg; BMI 19.6 kg/m². All vital signs are synthetic.

PHQ-9: 16. All results are synthetic.

## Change since baseline

- PHQ-9: 17 at baseline, 16 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Thin, carefully dressed, tired |
| Mental status | Formal, then candid; speech slow; mood "heavy"; affect constricted, tearful when speaking of the friend she lost two years ago; thought process linear; no suicidal ideation; no delusions of guilt, poverty, or illness; no hallucinations; insight and judgment good |
| Cardiovascular | Blood pressure 126/74 mmHg seated and 122/72 mmHg standing; pulse 76, regular |
| Musculoskeletal | Timed Up and Go 12 seconds; steady turning |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Major depressive disorder, single episode, moderate** (F32.1). Three months of pervasive low mood, loss of interest, early waking, poor appetite with weight loss, slowed thinking, guilt, and a passive death wish, with PHQ-9 17 then 16 and GDS-15 10. Hemoglobin 12.6 g/dL, MCV 92 fL, sodium 139 mmol/L, creatinine 0.74 mg/dL, glucose 88 mg/dL, calcium 9.4 mg/dL, albumin 3.8 g/dL, TSH 2.1 mIU/L, vitamin B12 410 pg/mL, and folate 9.8 ng/mL are normal, and the MoCA was 27, so no medical cause or cognitive disorder is found. Grief is part of the picture, but its pervasiveness, the weight loss, and the death wish point to a major depressive episode. Dr. Rasmussen-Hale confirms the diagnosis, with no bipolar or psychotic features. The passive death wish has not recurred. **S**
   - Sertraline 25 mg each morning for one week, then 50 mg if she has no side effects; review in about four weeks, sooner by telephone if needed.
   - Weekly individual interpersonal psychotherapy with the clinic psychologist, in private end-of-day sessions, focused on grief.
   - Safety plan reviewed and unchanged; 988 Suicide & Crisis Lifeline and the clinic number confirmed; medicines stay with her maid.
   - Sodium about four weeks after starting sertraline.
2. **Low mood, poor sleep, poor appetite, and weight loss** (R45.89). The presenting concern is explained by major depression, with poor dentition adding to the poor intake; it is superseded by the diagnosis. **S**
   - Managed under major depressive disorder.
3. **Chronic insomnia comorbid with depression** (G47.00). Insomnia Severity Index 19, with sleep-maintenance and early-morning waking for three months; diphenhydramine stopped. **S**
   - Cognitive behavioral therapy for insomnia: a sleep window of 1 am to 6:30 am, out of bed after 20 minutes awake, worry time in the early evening; no hypnotics.
4. **Partial loss of teeth with an ill-fitting partial denture** (K08.409). Painful chewing limits what she eats. **S**
   - Dental appointment for a new partial denture, booked in three weeks.
5. **Fall risk** (Z91.81). No orthostatic drop; Timed Up and Go 12 seconds; SSRIs raise fall risk in older adults. **S**
   - Balance and strength class twice a week; repeat the orthostatic blood pressure and gait check at the next visit.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | PHQ-9 | Baseline, then at least monthly during acute treatment; every 2 to 4 weeks in continuation | Completed today | 16, down from 17 (6 percent); item 9 scored 0 |
| Survey | GDS-15 | Baseline and to monitor response in adults 65 or older (monthly here) | Due | 10 at intake; next at the four-week review |
| Survey | Suicide risk reassessment (C-SSRS Since Last Visit and PHQ-9 item 9) | Every visit during active treatment | Completed today | No passive or active suicidal thoughts since intake; no behavior. Protective factors unchanged. Safety plan reviewed; medicines held by her maid |
| Laboratory | Workup for medical causes (blood count, metabolic panel, calcium, albumin, TSH, vitamin B12, folate) | Once, at the initial depression workup | Completed today | Results from the first visit reviewed today: all normal |
| Survey | Cognitive screen (MoCA) | At the initial workup in an older adult; repeat if concerns | Up to date | 27 at intake; no concerns |
| Survey | Bipolar screen at the initial workup | Once, at the initial depression workup | Completed today | Psychiatric interview today found no past manic or hypomanic episode; no Mood Disorder Questionnaire score is recorded |
| Medication safety | Medication review for drugs that worsen mood, sleep, or cognition | At the initial workup and at every visit | Completed today | Diphenhydramine stopped at intake; no other medicines |
| Medication safety | SSRI tolerability check two weeks after starting and after each dose change | 2 weeks after starting and after each dose change | Due | Sertraline starts today |
| Laboratory | Sodium after starting an SSRI in an older adult | About 2 to 4 weeks after starting | Due | Baseline 139 mmol/L; recheck at the four-week review |
| Referral | Geriatric psychiatry consultation | For depression in an older adult with a death wish and weight loss | Completed today | Seen today; diagnosis confirmed; sertraline and IPT agreed |
| Examination | Weight and nutrition | Every visit while weight is below her usual | Completed today | 52.1 kg, down 0.3 kg; supplement once a day |
| Examination | Fall risk on an SSRI: orthostatic blood pressure, gait, and falls since the last visit | At baseline, after starting an SSRI, and with dose changes | Completed today | No orthostatic drop; Timed Up and Go 12 seconds; no falls |
| Self-management | Psychotherapy, sleep, activity, and social contact | Every visit during active treatment | Completed today | IPT referral made; CBT-I rules started; walks in the gardens most days |
| Laboratory | Lithium, anticonvulsant, or antipsychotic monitoring (levels, metabolic tests, AIMS) | Only on those drugs | Not indicated | Treated with an SSRI only |

## Goal progress

- Medical causes of low mood and weight loss excluded by the second visit. Outcome by 2026-01-26: Blood count, metabolic panel, calcium, albumin, TSH, vitamin B12, folate, and MoCA normal; diphenhydramine stopped. **S**
- Response (PHQ-9 down by at least 50 percent) by twelve weeks of treatment, then remission (PHQ-9 below 5). In progress; target 2026-04-20. **S**
- No passive or active suicidal thoughts. Outcome by 2026-01-26: Passive death wish at intake only; PHQ-9 item 9 scored 0 from the second visit. **S**
- Sleep at least six hours most nights without hypnotics. In progress; target 2026-04-20. **S**
- Weight back to at least 55 kg, with a comfortable denture. In progress; target 2026-06-15. **S**

## Medication changes

- Started: Sertraline 25 mg oral tablet, one tablet by mouth each morning **S**

## Guideline basis

- APA Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019), American Psychological Association
- VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022), United States Department of Veterans Affairs and Department of Defense
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense
- CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026), Aether Forge
- American Geriatrics Society 2023 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults (2023), American Geriatrics Society (Journal of the American Geriatrics Society)
- Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians (2016), American College of Physicians (Annals of Internal Medicine)

## Follow-up

- Depression review in four weeks, with sodium and the GDS-15; telephone or same-day contact sooner if needed. **S**
- Next scheduled visit 2026-02-23: four-week depression treatment review with a sodium check. **S**
